Cooper Cos IncCOO
Price$57.41Intrinsic value$102.2978% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $102.29median of 6 methods · middle span $85-$119based on filings through 31 Jul 2026
Market Price $57.41Price as of 1 Oct 2026
Margin of Safety +78.2%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.4% (near-term consensus, capped) · years 2–5: 10.7%/yr (balance of the path).9.6% per year
Years 6–10: glide to demonstrated growth own history 40.2%, capped at 20%
Per-year rates
Yr 610.5%Yr 710.3%Yr 810.1%Yr 99.9%Yr 109.6%
10.7% → 9.6%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.0%Yr 128.3%Yr 137.6%Yr 147.0%Yr 156.3%Yr 165.7%Yr 175.0%Yr 184.3%Yr 193.7%Yr 203.0%
9.6% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)40.2%
Discount rate (cost of equity) 8.9%
Volatility vs market (adjusted beta)0.88

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetCooper Cos IncCOOHealth Care
Valuation
P/E19.7×
P/S2.4×
P/B1.3×
EV / Revenue3.0×
EV / EBITDA—
Profitability
Gross margin65.9%
Operating margin12.8%
Net margin13.5%
FCF margin16.0%
Returns
ROE6.8%
ROA4.5%
ROIC5.3%
Growth
Revenue growth (YoY)8.8%
5-yr fwd EPS growth9.6%
Financial strength
Debt / Equity0.31×
Current ratio1.22×
Altman Z-Score2.9
Interest coverage—
Dividend yield0.0%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.